Finally, we provide evidence that in colorectal cancer patient tissue, CTNNB1 mutations that eliminate Ser45 or Thr41 do not result in elevated β-catenin activity as assessed by Wnt target gene expression. Here, CTNNB1 is linked to colorectal cancer.